SCHEMBL6415036

SCHEMBL6415036

COc1nccnc1C(C)C1=C(CCN2CCC(F)C2)Cc2ccccc21

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 16/20 0.63
CYP2D6 P10635 13/20 0.63
CHRM1 P11229 12/20 0.63
KCNH2 Q12809 8/20 0.63
CHRM2 P08172 9/20 0.50
CHRM4 P08173 9/20 0.50
CHRM5 P08912 9/20 0.50
CHRM3 P20309 9/20 0.50
HRH2 P25021 1/20 0.50
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
TSHR P16473 1/20 0.39
CYP2C19 P33261 1/20 0.39
HTR1A P08908 1/20 0.39
ADRA2A P08913 1/20 0.39
DRD1 P21728 1/20 0.39
PTGS1 P23219 1/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
ADRA1A P35348 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6279572 0.91 HRH1 (0.61) HRH1CYP2D6CHRM1KCNH2CHRM2
SCHEMBL6420651 0.88 CYP2D6 (0.65) HRH1CYP2D6CHRM1KCNH2CHRM2
SCHEMBL6277449 0.88 CYP2D6 (0.67) HRH1CYP2D6CHRM1KCNH2CHRM2
SCHEMBL6416310 0.88 CYP2D6 (0.65) HRH1CYP2D6CHRM1KCNH2CHRM2
SCHEMBL6416764 0.86 HRH1 (0.70) HRH1CYP2D6CHRM1KCNH2CHRM2
SCHEMBL6272509 0.81 HRH1 (0.64) HRH1CYP2D6CHRM1KCNH2CHRM2
SCHEMBL6272284 0.80 HRH1 (0.66) HRH1CYP2D6CHRM1KCNH2CHRM2
SCHEMBL6270496 0.80 HRH1 (0.60) HRH1CYP2D6CHRM1KCNH2CHRM2
SCHEMBL6280226 0.79 CYP2D6 (0.63) HRH1CYP2D6CHRM1KCNH2CHRM2
SCHEMBL6277034 0.79 CYP2D6 (0.63) HRH1CYP2D6CHRM1KCNH2CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050277645-A1 Sleep inducing compounds and methods relating thereto NEUROCRINE BIOSCIENCES, INC. (US) 2005-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050277645-A1 Sleep inducing compounds and methods relating thereto CNR1, CNR2, MTNR1B HRH1 104/4885CYP2D6 74/4885CHRM1 12/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.